Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
AC Immune SA
AC Immune SA
(ACIU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
renal cell carcinoma
,
kidney neoplasms
,
prostatic neoplasms
,
heart failure
,
cardiomyopathies
,
sudden death cardiac
,
ventricular fibrillation
,
sudden death
,
breast neoplasms
,
neuroendocrine tumors
Gilvetmab
colorectal neoplasms
,
squamous cell neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
neoplasm metastasis
,
sarcoma
,
squamous cell carcinoma
,
merkel cell carcinoma
,
endometrial neoplasms
,
hepatocellular carcinoma
,
transitional cell carcinoma
,
head and neck neoplasms
,
pancreatic ductal carcinoma
,
colonic neoplasms
,
rectal neoplasms
,
triple negative breast neoplasms
,
mycoses
,
mycosis fungoides
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
pancreatic neoplasms
,
bile duct neoplasms
,
liver neoplasms
,
rectal diseases
,
melanoma
,
neoplasms
,
renal cell carcinoma
,
ovarian neoplasms
,
urologic neoplasms
,
carcinoma
,
lung neoplasms
,
breast neoplasms
,
ovarian epithelial carcinoma
,
adenocarcinoma
,
urologic diseases
,
kidney neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
urinary bladder diseases
,
neoadjuvant therapy
,
skin neoplasms
,
kidney diseases
,
urogenital neoplasms
,
neoplasms by site
,
glandular and epithelial neoplasms
,
non-small-cell lung carcinoma
,
squamous cell carcinoma of head and neck
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
Bevifimod
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Fludeoxyglucose f-18
ovarian neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
hepatocellular carcinoma
,
stomach neoplasms
,
melanoma
,
small cell lung carcinoma
,
cholangiocarcinoma
,
merkel cell carcinoma
,
mesothelioma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
b-cell lymphoma
,
burkitt lymphoma
,
cardiovascular diseases
,
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use